An underground economy for unlicensed slimming drugs is being driven by TikTok fitness influencers and sellers on communication apps, according to new investigations.
Experimental Drug Gaining Popularity Via Social Media
Retatrutide, which remains in clinical trials, is being advertised by social media influencers for its alleged weight-reducing properties. Followers are urged to contact these profiles directly for source information, while also receiving discount codes.
Active Trade on Messaging Platforms
Separately, a flourishing trade exists on messaging services, where communities with numerous of participants share comparison photos, injection guides and claims of next-day British shipping. Vendors promote the substance there before directing customers to other platforms for purchases.
Understanding Retatrutide
Retatrutide is an experimental injectable created by US drugmaker Eli Lilly. The treatment targets three gut hormones – glucagon-like peptide-1, GIP and glucagon. Early trials suggest it could assist patients lose up to a quarter of their total weight. Nicknamed the “triple G”, the drug is being promoted digitally as the next Ozempic.
Healthcare Professionals Voice Concerns
Nevertheless, physicians and chemists have cautions that the distribution of what is still an unapproved medication in the UK is worrisome and could result in individuals administering substances of unknown origin.
Some professionals said the demand for the experimental drug could be linked to the rising cost of approved slimming treatments such as Mounjaro.
Regulatory Position and Implementation
Marketing the unapproved drug on TikTok or Telegram is prohibited in the United Kingdom, as it is an unlicensed drug that must not be promoted or supplied for human use under the British medical regulations.
Some content creators attempt to sidestep the rules by calling to the drug as a “research chemical” or describing it as “not for human consumption”. Retatrutide is not a controlled substance, but advertising and supply can still violate pharmaceutical, marketing, and consumer laws, risking fines, prosecution or prison.
Platform Response and Material Removal
According to the social media company, the service has removed problematic content and banned related hashtags and search suggestions. The company said it was committed to maintaining the service secure and allocating resources in strengthening compliance measures.
Online Marketplace Activities
Investigations also found groups with up to 9,000 members selling the experimental drug using Telegram's built-in search feature, which functions like a online catalog. Typing “retatrutide” instantly brings up groups with thousands of users, filled with photos of slimming results, positive reviews and step-by-step instructions for mixing or administering at residence.
Within minutes of entering one community, a seller shared WhatsApp details, where most purchases take place. The vendor sent an instruction manual and guaranteed shipping within 48 hours. When asked whether the product was genuine, one seller responded: “You can’t be sure.” Another provided a photo of a supposed laboratory certificate. Not one inquired about body mass, medical conditions or previous experience.
Item Information and Costs
Within these communities, messages show dark colored packages with Royal Mail labels, claiming to include new batches. One communication stated: “It took eight of us to load them this morning.”
Customers can select between powder vials, mixed at home with sterile water, or pre-filled injectors typically priced at £160 for 20mg. When asked how long a injector should last, sellers give conflicting answers ranging from a several days to “depends on your body”.
Service Moderation and Safety Measures
A representative for Telegram stated it regularly monitored harmful material on its platform including content that promoted the “misuse of controlled medications”. The organization added that it removed “millions of pieces of harmful content each day”.
Medical Expert Cautions
“People are administering materials they cannot confirm. Even if the research behind this drug is valid, these online versions may not include what they advertise,” said Jason Murphy, the director of pharmacy at Chemist4U.
Dr Crystal Wyllie of an online medical service linked the increase in demand to recent cost increases for authorized slimming drugs such as Mounjaro. “With prices increasing, individuals are turning to social media. But fake injections are extremely dangerous. You cannot know what’s inside or whether the conditions they were made in was clean,” she said.
Her staff has already encountered patients harmed by self-injection from unconfirmed sources. “We understand the disappointment, but purchasing from Telegram or communication platforms is gambling with your well-being,” stated the doctor. “These substances could be impure or incorrectly dosed.”
Manufacturer Position
A representative from Eli Lilly said retatrutide was in phase 3 research studies and had not been reviewed or approved by any government authority globally. “Therefore at this point no one can sell [it] for personal consumption,” they said, noting that any product “falsely representing itself as a Lilly experimental product not yet approved … may expose users to possibly serious medical dangers”.
